drugset / Trial / NCT05345028

Boswellia Serrata Extract in Acute Diarrhea

NCT05345028

RandomizedParallel-groupTriple-blindTreatment

Summary

Acute diarrhea is a frequent problem worldwide, mostly due to gastrointestinal infections or food poisoning. Boswellia serrata could be active in the treatment of acute diarrhea due to its an-ti-inflammatory, antispasmodic and antimicrobial activity.

Timeline

Start
2021-03-03
Primary completion
2021-05-24
Completion
2021-09-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Boswellia Serrata Extract Unknown 250 mg

Indications